LVTX   $1.6800000000000002  0.0 Market Closed

LAVA Therapeutics NV
Total Cash 86.80M
totalCashPerShare 3.301
EBITDA -26.88M
Total Debt 6.16M
quickRatio 6.233
currentRatio 6.39
Total Revenue 7.40M
debtToEquity 14.373
Revenue/Share 0.274
ROA -0.15991001
ROE -0.45299
grossProfits
freeCashflow -17.98M
operatingCashflow -27.08M
earningsGrowth
revenueGrowth
grossMargins 0.97783
ebitdaMargins 0.0
operatingMargins -3.71479
profitMargins 0.0
enterpriseValue -35.41M
forwardPE -0.87113404
floatShares 12.09M
sharesOutstanding 26.30M
sharesShort 45.43K
sharesShortPriorMonth 41.97K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.29%
heldPercentInstitutions 0.32%
Short Ratio help_outline 0.92%
shortPercentOfFloat 0.00%
impliedSharesOutstanding
bookValue 1.631
Price To Book help_outline 1.04
earningsQuarterlyGrowth
netIncomeToCommon -24.18M
trailingEps -0.89%
forwardEps -1.94%
enterpriseToEbitda 1.32
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.33 3Q 2024
institutionsCount 22
lastUpdated Sept. 16, 2024, 8:18 p.m.